ReportsandReports – Slovenia Pharmaceuticals and Healthcare Report Q4 2010
In BMI’s Business Environment Ratings (BERs) table for Q410, Slovenia is ranked ninth of the 20 markets assessed in CEE, up by one place in relation to the previous quarter. Overall, Slovenia’s attractiveness suffers from a small market size and low forecast growth, although the high per-capita GDP and widespread health awareness play in favour of pharmaceutical companies.
View full press release